CareDx (NASDAQ: CDNA)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-28 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.050 | -0.130 | -0.0800 | ||||
REV | 78.920M | 79.416M | 496.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of CareDx (NASDAQ: CDNA) through any online brokerage.
Other companies in CareDx’s space includes: Valneva (NASDAQ:VALN), Chinook Therapeutics (NASDAQ:KDNY), Syndax Pharmaceuticals (NASDAQ:SNDX), Prothena Corp (NASDAQ:PRTA) and Arcutis Biotherapeutics (NASDAQ:ARQT).
The latest price target for CareDx (NASDAQ: CDNA) was reported by Raymond James on Friday, May 6, 2022. The analyst firm set a price target for 45.00 expecting CDNA to rise to within 12 months (a possible 79.93% upside). 4 analyst firms have reported ratings in the last year.
The stock price for CareDx (NASDAQ: CDNA) is $25.01 last updated July 6, 2022, 8:00 PM UTC.
There are no upcoming dividends for CareDx.
CareDx’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for CareDx.
CareDx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.